Editor's Note
The Joint Commission announced December 11 that during the appeals process of he United States Pharmacopeia (USP) 797 chapter revisions, it will evaluate organizations based on the version they have adopted−either 2008 or the 2019 revised chapter.
Organizations may not independently choose specific components from both versions, but they should adopt in full the version selected, the Joint Commission says.
Perioperative leaders are entering a time of uncertainty after 2024…
Takeaways • Requirements for improvement and condition level deficiency findings…
Reliable and robust enough for daily use on most medical…